$CNAT merger vote on May 21, additionally Histogen, their merger partner just got FDA IND approval to start trials. I really like this play for .75-1.00 area. The float is tight and really has not received the volume all these other merger plays are getting. 12-15m volume and I think it will double or better.
News 
Market Data 
Discover 
